Basic Information
RNALocate ID: | RLID-D:11001505 |
RNA Symbol: | hsa-miR-138-2-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-138-2-3p |
RNA ID: | miRBase:MIMAT0004596 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003735 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11003736 | Exosome | Plasma | 23663360 |
RLID-D:11004085 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-138-2-3p | Oral squamous cell carcinoma | MNDR-E-MI-12847 |
MNDR | hsa-miR-138-2-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-12848 |
MNDR | hsa-miR-138-2-3p | Lymphoma | MNDR-E-MI-12849 |
MNDR | hsa-miR-138-2-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-12850 |
MNDR | hsa-miR-138-2-3p | B cell acute lymphoblastic leukemia | MNDR-E-MI-12851 |
MNDR | hsa-miR-138-2-3p | Gastric cancer | MNDR-E-MI-12852 |
MNDR | hsa-miR-138-2-3p | Alzheimer disease | MNDR-E-MI-12853 |
MNDR | hsa-miR-138-2-3p | Leukemia | MNDR-E-MI-12854 |
MNDR | hsa-miR-138-2-3p | Huntington disease | MNDR-E-MI-12855 |
MNDR | hsa-miR-138-2-3p | Chorea | MNDR-E-MI-12856 |
MNDR | hsa-miR-138-2-3p | Lung cancer | MNDR-E-MI-12857 |
MNDR | hsa-miR-138-2-3p | Parkinson disease | MNDR-E-MI-12858 |
MNDR | hsa-miR-138-2-3p | Pancreatic cancer | MNDR-E-MI-12859 |
MNDR | hsa-miR-138-2-3p | Colon cancer | MNDR-E-MI-12860 |
MNDR | hsa-miR-138-2-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-12861 |
MNDR | hsa-miR-138-2-3p | Familial ovarian cancer | MNDR-E-MI-12862 |
MNDR | hsa-miR-138-2-3p | Glioblastoma | MNDR-E-MI-12863 |
MNDR | hsa-miR-138-2-3p | Astrocytoma | MNDR-E-MI-12864 |
MNDR | hsa-miR-138-2-3p | Pituitary adenoma | MNDR-E-MI-12865 |
MNDR | hsa-miR-138-2-3p | Non-small cell lung adenocarcinoma | MNDR-E-MI-12866 |
MNDR | hsa-miR-138-2-3p | Lung adenocarcinoma | MNDR-E-MI-12867 |
MNDR | hsa-miR-138-2-3p | Papillary thyroid carcinoma | MNDR-E-MI-12868 |
MNDR | hsa-miR-138-2-3p | Ovarian carcinoma | MNDR-E-MI-12869 |
MNDR | hsa-miR-138-2-3p | Pancreatic adenocarcinoma | MNDR-E-MI-12870 |
MNDR | hsa-miR-138-2-3p | Clear cell renal cell carcinoma | MNDR-E-MI-12871 |
MNDR | hsa-miR-138-2-3p | Hepatocellular carcinoma | MNDR-E-MI-12872 |
MNDR | hsa-miR-138-2-3p | Familiar ovarian carcinoma | MNDR-E-MI-12873 |
MNDR | hsa-miR-138-2-3p | Retinoblastoma | MNDR-E-MI-12874 |
MNDR | hsa-miR-138-2-3p | Colorectal cancer | MNDR-E-MI-12875 |
MNDR | hsa-miR-138-2-3p | Nasopharynx carcinoma | MNDR-E-MI-12876 |
MNDR | hsa-miR-138-2-3p | Nasopharyngeal cancer | MNDR-E-MI-12877 |
TOP